Veterinary Cardiology Market Size, Share & Trends Analysis Report By Animal Type (Companion, Production), By Product (Pharmaceuticals, Diagnostics), By Indication, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
Veterinary Cardiology Market Size & Trends
The global veterinary cardiology market size was valued at USD 2.79 billion in 2024 and is projected to grow at a CAGR of 8.41% from 2025 to 2030. The high prevalence of cardiologic disorders among companion animals, particularly dogs, is a significant market driver for the veterinary cardiology sector. Research indicates that approximately 10% of all dogs seen in primary care animal settings are diagnosed with heart disease, with this figure rising to over 60% in older dogs. Among these cases, myxomatous mitral valve disease (MMVD) stands out, accounting for 75% of canine heart disease cases in the U.S., primarily affecting heart valves. Another critical condition, dilated cardiomyopathy (DCM), directly impacts the heart muscle. The widespread occurrence of these disorders underscores the growing demand for advanced diagnostics, therapeutics, and specialized animal care, fueling the expansion of the market.
For instance, in June 2024, the Indian Council for Agricultural Research published a study examining the incidence of cardiac arrhythmias in 435 dogs with a history of generalized diseases over 14 months from July 2022 to September 2023. The assessment was aimed to determine the occurrence of arrhythmias and found that 114 dogs (26.21%) displayed various types, including atrial fibrillation (30.70%), ST-segment coving, sinus arrest (9.65% each), and ST-segment elevation (8.77% each). Moreover, there is a rising prevalence of CHD among cattle which is further driving the market growth. For instance, according to the Large Animal Review (LAR) study published in June 2023, CHD is a heart condition that is present at birth, with a reported prevalence ranging from 0.2% to 2.7% in cattle.
Moreover, the increasing awareness regarding preventive health has led pet owners to spend more on their health to improve their overall well-being. The rising expenditure on animal care is a notable driver for the growth of the market. According to the article published in February 2024, the Bureau of Labor Statistics found that the cost of veterinary services increased by 7.5% from September 2022 to September 2023. This upward trend reflects growing pet ownership, heightened awareness of pet health, and advancements in veterinary diagnostics and treatments. As pet owners increasingly prioritize specialized care, including cardiology services, this surge in spending supports the demand for innovative solutions and expanded animal cardiology offerings.
The growing advancements in animal medications and knowledge about various treatment options available for different disorders, including heart diseases that pets may face, are propelling the market growth. Pet health awareness programs enable pet owners to explore these treatment options. For instance, in June 2023, the Veterinary Innovation Summit (VIS) was organized to bring together professionals, innovators, and thought leaders in the field of animal health care to discuss and shape the future of veterinary medicine. VIS 2023 is expected to be a groundbreaking event that is likely to inspire attendees to drive innovation and advancements in animal health care.
Global Veterinary Cardiology Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global veterinary cardiology market report on the basis of animal type, product, indication, end use, distribution channel, and region:
- Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
- Companion Animals
- Dogs
- Cats
- Horses
- Others
- Production Animals
- Cattle
- Poultry
- Others
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceuticals
- Pimobendan
- Spironolactone and benazepril hydrochloride
- Others
- Diagnostics
- Physical exam
- Chest X-rays
- Electrocardiogram (ECG)
- Others
- Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Congestive Heart Failure
- Myocardial (Heart Muscle) Disease
- Arrhythmias
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Veterinary Hospitals & Clinics
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital/ Clinic Pharmacy
- Retail
- E-Commerce
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Rest of MEA
Please note The report will be delivered in 2-3 business days upon order notification.